Prospect: information for the user
Metasedin 5 mg tablets
Metadone hydrochloride
Read this prospect carefully before starting to take the medicine, as it contains important information for you.
1.What is Metasedin and for what it is used
2.What you need to know before starting to take Metasedin
3.How to take Metasedin
4.Possible adverse effects
5.Storage of Metasedin
6. Contents of the package and additional information
Metasedin 5 mg tablets are a medication that contains a substance called methadone, belonging to the group of narcotic analgesic drugs. Methadone is a central analgesic of slightly higher potency than morphine. It also produces less euphoria and a withdrawal syndrome similar, although more prolonged.
Metasedin 5 mg tablets are indicated for intense pain of any etiology. Post-operative, post-traumatic, neoplastic, neuritic, burn pain, whenever they do not respond to minor analgesics. Treatment of narcotic withdrawal syndrome.
Do not take Metasedin
Warnings and precautions
Consult your doctor or pharmacist if you experience any of the following symptoms before starting or while taking Metasedin:
Tolerance, dependence, and addiction
This medication contains an opioid called methadone. Repeated use of opioids can reduce the effectiveness of the medication (your body becomes accustomed to the medication, which is known as tolerance). Repeated use of Metasedin can also cause dependence, abuse, and addiction, which can lead to a potentially fatal overdose.
The risk of adverse effects may increase with higher doses and longer duration of use.
Dependence or addiction may make you feel like you no longer have control over the amount of medication you need to take or how often you need to take it. When used to treat pain, you may feel like you need to continue taking the medication, even if it no longer helps alleviate your pain.
The risk of becoming dependent or addicted varies from person to person. You may be at a higher risk of becoming dependent or addicted to Metasedin if:
-You or a family member has a history of alcohol, prescription medication, or illicit substance abuse (“addiction”).
-You are a smoker.
-You have had problems with your mood (depression, anxiety, or a personality disorder) or have received treatment from a psychiatrist for other mental health conditions.
If you notice any of the following signs while taking Metasedin, it could be a sign that you have become dependent or addicted.
-You need to take the medication for longer than recommended by your doctor.
-You need to take more doses than recommended.
-You are using the medication for reasons other than those prescribed, such as “to calm down” or “to help you sleep”.
-You have made repeated unsuccessful attempts to stop or control your use of the medication.
-You do not feel well when you stop taking the medication and feel better when you take it again (“withdrawal symptoms”).
If you notice any of these signs, talk to your doctor to address the most appropriate therapeutic strategy for your case, including when it is appropriate to stop taking it and how to do it safely (see section 3 “If you interrupt treatment with Metasedin”).
Respiratory disorders related to sleep
Methadone may cause respiratory disorders related to sleep such as, for example, sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, nocturnal awakenings due to lack of breath, difficulty maintaining sleep, or excessive daytime somnolence. If you or someone else observes these symptoms, contact your doctor. Your doctor may consider reducing the dose.
Use in athletes
This medication contains a component that can produce a positive result in doping control tests.
Children and adolescents
Metasedin is not recommended for use in children and adolescents under 18 years of age due to the lack of safety and efficacy data in this population. Additionally, children are more sensitive to the effects of methadone than adults.
Other medications and Metasedin
There are some medications that can affect the proper functioning of Metasedin or Metasedin itself may reduce the effectiveness of other medications being taken at the same time. These medication interactions can increase or decrease the effect of one of the two medications, and may increase the risk or severity of adverse effects.
Do not take Metasedin if you are taking monoamine oxidase inhibitors (MAOIs) or have taken an MAOI in the last two weeks.
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication such as:
Taking Metasedin with food, drinks, and alcohol
Alcohol may increase the side effects of methadone, so it should not be taken during treatment with this medication.
Orange juice may modify the effect of methadone, so it should not be taken with Metasedin.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication.
Pregnancy
If Metasedin is used during pregnancy, your baby may experience withdrawal symptoms. Be careful if you are taking a pregnancy test, as methadone may interfere with the results.
Metasedin should not be used if you are in labor.
Breastfeeding
Methadone is excreted in breast milk. Metasedin will only be administered to breastfeeding mothers when the benefits for the infant outweigh the potential risks. Breastfeeding in these cases may prevent the onset of withdrawal symptoms in the newborn.
Consult your doctor if you are breastfeeding or planning to do so while taking methadone, as it may affect your baby. Monitor your baby for any abnormal signs and symptoms, such as excessive sleepiness (more than usual), difficulty breathing, or weakness. Immediately contact your doctor if you observe any of these symptoms.
Driving and operating machinery
Methadone may cause drowsiness, dizziness, or other symptoms that may impair your ability to drive. If you experience any of these adverse effects, avoid driving vehicles or operating machinery.
Metasedin contains lactose
This medication contains lactose. If your doctor has indicated that you have a lactose intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and periodically during it, your doctor will talk to you about what you can expect from the use of Metasedin, when and for how long you should take it, when to contact your doctor and when to stop taking it (see also “If you interrupt treatment with Metasedin”).
The dosage must be individualized, so your doctor will establish the appropriate dose for you and make any necessary adjustments.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
Use in adults:
1 to 2 tablets per dose, according to the intensity of the pain. This dose may be repeated as deemed necessary by your doctor.
The tablets should be swallowed without chewing, with a little water.
Remember to take your medication.
Your doctor will indicate the duration of treatment with Metasedin.
If you take more Metasedin than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you take too much metadone you may experience:
In case of extreme intoxication, respiratory arrest, circulatory collapse, heart failure, and death may occur.
If you forgot to take Metasedin
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Metasedin
Abruptly stopping treatment, in patients with physical dependence, may precipitate an abstinence syndrome. Your doctor will indicate how to gradually reduce the dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
Metadone generally causes side effects similar to those of morphine.
The most serious side effects of metadone, as with other opioids, are respiratory depression (difficulty breathing) and, to a lesser extent, a decrease in blood pressure, with cases of respiratory arrest, shock, and cardiac arrest occurring. The most frequent side effects are dizziness, sedation, nausea, vomiting, and excessive sweating. These side effects appear to be more intense in ambulatory patients and those who do not have intense chronic pain. In these patients, it is recommended to use lower doses. Some side effects may be alleviated if the patient lies down.
Inform your doctor immediately if you experience:
Other possible side effects may be the following:
Very frequent (may affect more than 1 in 10 patients)
nausea, vomiting.
Frequent (may affect up to 1 in 10 patients)
excessive sweating
fatigue, drowsiness, sedation
weight gain
fluid retention
constipation
eruption, which may appear and disappear
blurred vision, small pupils, dry eyes
dizziness, vertigo
changes in mood, feeling too excited (euphoria) or seeing or hearing things that are not real (hallucinations)
Rare (may affect up to 1 in 100 patients)
difficulty breathing (respiratory depression), especially with high doses
worsening of asthma
low blood pressure
headache, syncope, or sudden loss of consciousness
feeling disheartened (disphoria), agitation, confusion, disorientation, difficulty sleeping
You may become dependent on Metasedin, for more information, see section 2 “Warnings and precautions”
itching, skin eruptions, urticaria
dry mouth or nose, inflammation of the tongue, facial redness
difficulty urinating (urinary retention), lower back and abdominal pain caused by muscle spasms
alteration of bile duct movement (may manifest as nausea, vomiting, or both, biliary pain in the upper right abdomen or radiating to the right shoulder region)
low body temperature (hypothermia)
sensation of weakness, fatigue
decreased libido or difficulty achieving or maintaining an erection
menstrual cramps, absence of menstruation
milk secretion from the nipple (galactorrhea)
fluid accumulation in the lungs (pulmonary edema)
Rare (may affect up to 1 in 1000 patients)
changes in heart rhythm (both rapid heartbeats and missed beats)
electrocardiogram (ECG) anomaly, known as prolongation of the QT interval, which may appear as an alteration in heart rhythm called “torsade de pointes” (especially with high doses of metadone)
cardiac arrest
shock
respiratory arrest
Other reported side effects, of unknown frequency, are
loss of appetite
swelling, swollen legs (this may be a sign that your body is retaining more water than normal)
increased intracranial pressure (especially with high doses)
involuntary, rapid, and repetitive eye movements, strabismus
reduced visual acuity
sleep apnea (pauses in breathing during sleep)
reduction of blood platelets, which increases the risk of bleeding or hematomas in patients with chronic hepatitis
low potassium and magnesium levels
decreased production of adrenal and sex hormones
low blood sugar levels
elevated prolactin levels in the blood
If you observe any other reaction not described in this prospectus, consult your doctor or pharmacist.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even ifit is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use, Website:www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children. Store this medication in a safe and secure location where other individuals cannot access it. It may cause severe harm and be fatal to people who have not been prescribed it.
Do not store at a temperature above 25°C.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Metasedin
Appearance of the product and content of the packaging
Metasedin 5 mg tablets are presented in the form of white, circular, biconvex tablets, in packaging with 20 tablets and 800 tablets (Clinical packaging).
Some packaging sizes may not be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Spain
Responsible for manufacturing
Towa Pharmaceutical Europe, S.L.
c/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Last review date of this leaflet: March 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.